How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

935 results for

Medication Causes of Dyspepsia

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Hea

for Treatment or Prevention of VA e290 5.1. Medication Therapy e290 5.1.1. Medications With Prominent Sodium Channel Blockade e290 5.1.2. Beta Blockers e293 5.1.3. Amiodarone and Sotalol e293 5.1.4. Calcium Channel Blockers e294 5.1.5. Nonantiarrhythmic Medications and Therapies e294 5.2. Preventing SCD With HF Medications e295 5.3. Defibrillators for Treatment of VA and SCD e295 5.4. Catheter Ablation e295 5.4.1. General Considerations e295 5.4.2. VA in Patients With No Apparent Structural Heart Disease (...) (Belhassen Tachycardia) e335 8.4. Idiopathic Polymorphic VT/VF e336 9. PVC-Induced Cardiomyopathy e337 10. VA and SCD Related to Specific Populations e338 10.1. Athletes e338 10.2. Pregnancy e338 10.3. Older Patients With Comorbidities e339 10.4. Chronic Kidney Disease e340 10.5. Valvular Heart Disease e340 10.6. Sex-Related Differences in the Risk of SCD e340 10.7. Medication-Induced Arrhythmias e341 10.8. Adult Congenital Heart Disease e342 11. Defibrillators Other than Transvenous ICDs e347 11.1

2017 American Heart Association

142. Diagnosis and Treatment of H. pylori Infection in Adults

OF HELICOBACTER pylori IN ADULTS* *Excluding pregnant or breastfeeding women See TOP’s Chronic Undiagnosed Dyspepsia CPG Order urea breath test (UBT) to test for H. pylori See Dynalife and Calgary Lab Services instructions Consider other (non- ulcer) causes of dyspepsia symptoms Select an eradication (See Table 1) Consider re-test UBT for eradication in certain patients Select second line rescue therapy (see Table 1) and Re-test UBT Failure to respond to therapy >2 times (...) approach for dyspeptic patients without alarm features. See Algorithm (summarizing diagnosis and treatment process described below). ? Patients who would benefit from H. pylori testing using UBT include: o Dyspepsia and younger ( 50 years of age o No or limited response to acid-suppression treatment o Dyspepsia and any alarm features PRACTICE POINT When further assessment is required for dyspeptic patients, upper GI endoscopy is the preferred investigation. Barium swallow or CT scan can be ordered

2016 Toward Optimized Practice

143. Management of Opioid Therapy (OT) for Chronic Pain

prescriptions were still written in 2012.[11] The increase in opioid prescribing is matched by a parallel increase in morbidity, mortality, opioid-related overdose death rates, and substance use disorders (SUD) treatment admissions from 1999 to 2008.[12,13] In 2009, drug overdose became the leading cause of injury-related death in the U.S., surpassing deaths from traffic accidents.[14] In 2014, 1.9 million Americans were affected by an OUD related to non-medical use of prescription pain relievers,[15 (...) , Washington, DC & Office of Evidence Based Practice, U.S. Army Medical Command Version 3.0 – 2017 Based on evidence reviewed through December 2016V A / D o D Cli ni cal P r a cti ce G ui d el i n e f o r O p ioid T h e r a p y for Ch r on ic Pa in February 2017 Page 3 of 198 Table of Contents I. Introduction 5 II. How to Use This Clinical Practice Guideline 6 7 10 11 12 13 14 15 15 16 16 19 20 21 21 26 26 27 27 31 III. Recommendations IV. Algorithm A. Module A: Determination of Appropriateness for Opioid

2017 VA/DoD Clinical Practice Guidelines

144. Proton Pump Inhibitors (PPIs): Is Perpetual Prescribing Inevitable?

: Extra one in 2000 women over eight years. 10 o Pneumonia. 11 o Vitamin B12 and magnesium deficiencies. 12,13 • Abruptly stopping PPIs may cause transient rebound GERD or dyspepsia symptoms. 14,15 o Tapering may help. 6 • Long-term PPIs should be considered for patients with recurrent symptoms, endoscopic esophagitis, complications from GERD (example: stricture), or those requiring gastroprotection. Authors: Michael R. Kolber BSc MD CCFP MSc, Tony Nickonchuk BSc Pharm Disclosure: Authors do not have (...) Proton Pump Inhibitors (PPIs): Is Perpetual Prescribing Inevitable? Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,500 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca

2017 Tools for Practice

145. Dyslipidaemias

Article Contents Article Navigation 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias Alberico L Catapano (Chairperson) (Italy) Corresponding authors: Alberico L. Catapano, Department of Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, and Multimedica IRCCS (MI) Italy. Tel: +39 02 5031 8401, Fax: +39 02 5031 8386, E-mail: ; Ian Graham, Cardiology Department, Hermitage Medical Clinic, Old Lucan Road, Dublin 20, Dublin, Ireland. Tel: +353 1 (...) 6459715, Fax: +353 1 6459714, E-mail: Search for other works by this author on: Ian Graham (Chairperson) (Ireland) Corresponding authors: Alberico L. Catapano, Department of Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, and Multimedica IRCCS (MI) Italy. Tel: +39 02 5031 8401, Fax: +39 02 5031 8386, E-mail: ; Ian Graham, Cardiology Department, Hermitage Medical Clinic, Old Lucan Road, Dublin 20, Dublin, Ireland. Tel: +353 1 6459715, Fax: +353 1 6459714

Full Text available with Trip Pro

2016 European Society of Cardiology

146. Musculoskeletal Strains and Sprains - Guidelines for Prescribing NSAIDs

Other medications -- some medications can cause pain as a side effect (see below) Musculoskeletal strains and sprains are assessed based on history and the presence of pain and swelling. Rule out the following conditions that may present with similar signs and symptoms: Fracture - indicated by marked bruising, swelling, deformity, bone tenderness, or inability to bear weight. Tendon rupture - indicated by inability to move muscle. Cartilage injury - indicated by tearing sensation, severe pain (...) a GI disorder such as ulcers: Naproxen or diclofenac Medium risk: Ketoprofen Lowest risk: Ibuprofen, celecoxib Other safety concerns Renal impairment: If CrCl <30 ml/min, avoid use of NSAIDs. Those with less compromised renal function may use NSAIDs short-term, but caution is still required, especially if they are on other medications such as diuretics or ACE-inhibitors. Pulmonary effects: NSAIDs can induce an asthma attack in some patients. ASA is the most common cause, and COX-2 inhibitors have

2017 medSask

147. Treatment of Helicobacter pylori Infection

. L e o n tiadis , MD , PhD 2 , C o lin W . H o w den , MD , F A C G 3 a n d S t e v en F . M os s , MD , F A C G 4 Helicobacter pylori ( H. pylori ) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taking low-dose aspirin or starting therapy with a non-steroidal anti-in? ammatory medication, unexplained iron de? ciency anemia (...) advances have been made in the arena of medical treatment. Th us, this guideline is intended to provide clinicians working in North America with updated recommendations on the treatment of H. pylori infection. For the purposes of this document, we have defi ned North America as the United States and Canada. When- ever possible, recommendations are based upon the best available evidence from the world’s literature with special attention paid to literature from North America. When evidence from North

2017 American College of Gastroenterology

148. Gastro-oesophageal reflux disease in children and young people: diagnosis and management

that causes symptoms (for example, discomfort or pain) severe enough to merit medical treatment, or to gastro-oesophageal reflux-associated complications (such as oesophagitis or pulmonary aspiration). In adults, the term GORD is often used more narrowly, referring specifically to reflux oesophagitis. Mark Marked distress ed distress There is very limited evidence, and no objective or widely accepted clinical definition, for what constitutes 'marked distress' in infants and children who are unable (...) subsequent treatment. 1.3.7 Do not offer metoclopramide, domperidone or erythromycin to treat GOR or GORD without seeking specialist advice and taking into account their potential to cause adverse events. 1.4 Enteral tube feeding for GORD 1.4.1 Only consider enteral tube feeding to promote weight gain in infants and children with overt regurgitation and faltering growth if: other explanations for poor weight gain have been explored and/or and/or recommended feeding and medical management of overt

2015 National Institute for Health and Clinical Excellence - Clinical Guidelines

149. Gallstone disease: diagnosis and initial management

population are thought to have gallstone disease, and most of these people experience no symptoms. For a small proportion of people with gallstone disease, the stones irritate the gallbladder or block part of the biliary system, and this can cause symptoms such as pain, infection and inflammation. If these symptoms are left untreated, gallstones can cause more serious and in some cases life-threatening conditions such as cholecystitis, cholangitis, pancreatitis and jaundice. There is variation in how (...) their symptoms until they have their gallbladder or gallstones removed. 1.4.2 Advise people that they should not need to avoid food and drink that triggered their symptoms after they have their gallbladder or gallstones removed. 1.4.3 Advise people to seek further advice from their GP if eating or drinking triggers existing symptoms or causes new symptoms to develop after they have recovered from having their gallbladder or gallstones removed. Gallstone disease: diagnosis and management (CG188) © NICE 2018

2014 National Institute for Health and Clinical Excellence - Clinical Guidelines

150. LINX® reflux management system

as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for a health professional's advice. It must not be relied upon without verification from authoritative sources. Queensland Health does not accept any liability, including for any injury, loss or damage, incurred by use of or reliance on the information. This Brief was commissioned by Queensland Health, in its role as the Secretariat (...) stomach contents from entering the LOS. 2, 3 The LINX device permits natural physiologic function to enable swallowing or release of elevated gastric pressure (associated with belching or vomiting). 1 This is achieved when the peristaltic pressure of the food bolus, for example, is greater than the magnetic attraction between adjacent beads of the LINX System, causing them to expand and ‘open’ the device. As the food moves through the oesophagus into the stomach and the peristaltic pressure drops

2016 COAG Health Council - Horizon Scanning Technology Briefs

151. MASCC and ESMO Consensus Guidelines for the Prevention of Chemotherapy and Radiotherapy-Induced Nausea and Vomiting

,TheNetherlands introduction Despite the considerable progress achieved in the last 30 years, vomiting and, especially, nausea, continue to be twoof the most distressing side-effects of cancer chemotherapy. In the late 1990s, several professional organisations published recommen- dations on the optimal antiemetic prophylaxis in patients sub- mitted to chemotherapy and/or radiotherapy. The European Society of Medical Oncology (ESMO) and the Multinational Association of Supportive Care in Cancer (MASCC (...) with ondansetron plus dexamethasone (48% versus 12%) [59]. The second trial compared ondansetron plus aprepitant with/ Volume27 | Supplement5 | September2016 doi:10.1093/annonc/mdw270 | v??? AnnalsofOncology clinicalpracticeguidelineswithout dexamethasone versus ondansetron plus placebo with/ without dexamethasone [60]. A complete response rate (no vomiting, no retching and no use of rescue medications) of 65% was reported in the ondansetron plus aprepitant arm versus 51% in the ondansetron arm for the ?rst 24

2017 European Society for Medical Oncology

152. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

, 4, 6962 Viganello-Lugano, Switzerland. E-mail: and/or to The MASCC Office. E-mail: Search for other works by this author on: R. J. Gralla 5Albert Einstein College of Medicine, Jacobi Medical Center, New York * Correspondence to: c/o ESMO Guidelines Committee, ESMO Head Office, Via Luigi Taddei, 4, 6962 Viganello-Lugano, Switzerland. E-mail: and/or to The MASCC Office. E-mail: Search for other works by this author on: E. Bruera 6Department of Palliative, Rehabilitation and Integrative Medicine (...) , Johannesburg, South Africa * Correspondence to: c/o ESMO Guidelines Committee, ESMO Head Office, Via Luigi Taddei, 4, 6962 Viganello-Lugano, Switzerland. E-mail: and/or to The MASCC Office. E-mail: Search for other works by this author on: J. Roscoe 15Department of Surgery, University of Rochester Medical Center, Rochester, USA * Correspondence to: c/o ESMO Guidelines Committee, ESMO Head Office, Via Luigi Taddei, 4, 6962 Viganello-Lugano, Switzerland. E-mail: and/or to The MASCC Office. E-mail: Search

Full Text available with Trip Pro

2016 International Society for Oral Oncology

153. Lymphangioleiomyomatosis Diagnosis and Management Part I: An Official ATS/JRS Clinical Practice Guideline

reported to recur in transplanted lungs, consistent with a metastatic mechanism for the disease (14, 15), but has not been reported to cause graft failure or to jeopardize eligibility for transplant. Genetic studies have revealed clonal origins for neoplastic cells harvested from pulmonary and extrapulmonary lesions of individual patients (16, 17). The neoplastic cells that in?ltrate the lung in patients with LAM have smooth muscle characteristics and a benign histological appearance (18), arise from (...) , important, or not important (27). LiteratureSearchandStudySelection In collaboration with an ATS methodologist (J.L.B.), a search strategy was designed using medical subject heading keywords and text words. The searches were limited to human studies and articles in English or in any language with English abstracts. A librarian from the National Institute of Health (K.S.) performedtheinitialliteraturesearchin2009. Four databases were searched: MEDLINE, EMBASE, Web of Science, and Scopus. AMERICAN

2016 American Thoracic Society

154. Management of Acute and Recurrent Gout: A Clinical Practice Guideline from the American College of Physicians

in patients with acute gout. These drugs have known anti-inflammatory activity and have been shown to reduce pain in many conditions. Further, they have been successfully used to prevent gout flares during urate-lowering therapy. The main harms of NSAIDs are gastrointestinal adverse effects ranging from minor (dyspepsia) to serious (perforations, ulcers, and bleeding). Long-term use of higher doses can cause chronic renal insufficiency. Corticosteroids There were no placebo-controlled trials of oral (...) publication, or once an update has been issued. Disclaimer: The authors of this article are responsible for its contents, including any clinical or treatment recommendations. Financial Support: Financial support for the development of this guideline comes exclusively from the ACP operating budget. Disclosures: Dr. Barry reports grants and personal fees from the Informed Medical Decisions Foundation and Healthwise outside the submitted work. Dr. Boyd reports royalties from UpToDate outside the submitted

Full Text available with Trip Pro

2016 American College of Physicians

155. Screening and Management of Lipids

obtaining data. Assess ASCVD risk factors • Clinical atherosclerotic cardiovascular disease (ASCVD includes stroke; peripheral arterial disease; coronary heart disease). • LDL-C = 190 mg/dL and age = 21,not caused by drugs or underlying medical condition (Table 1). • Diabetes mellitus type 1 or 2, age 40-75 years of age with LDL-C 70-189 mg/dL. • 10-year ASCVD risk = 7.5% for ages 40-75years (see Table 2 for calculation information). • CKD.(If CKD, see the UMHS CKD guideline for managing lipids in CKD (...) , but have had no effect on mortality, and in some instances have been associated with increased adverse events. For this reason, they are considered second line medications for CHD prevention and are primarily reserved for patients with severe triglyceride elevation (> 500 mg/dl) despite lifestyle changes to prevent pancreatitis. Adverse effects are generally GI, including nausea, dyspepsia, and change in bowel habits. The risk of cholestasis and cholecystectomy is increased. Fibrates carry a small risk

2016 University of Michigan Health System

156. Acne clinical guideline

Acne clinical guideline Guidelines of care for the management of acne vulgaris - Journal of the American Academy of Dermatology Email/Username: Password: Remember me Search JAAD & JAAD Case Reports Search Terms Search within Search Access provided by Volume 74, Issue 5, Pages 945–973.e33 Guidelines of care for the management of acne vulgaris Work Group:, x Andrea L. Zaenglein Affiliations Penn State Hershey Medical Center, Hershey, Pennsylvania , MD (Co-Chair) a , x Arun L. Pathy Affiliations (...) Kaiser Permanente, Centennial, Colorado , MD (Co-Chair) b , x Bethanee J. Schlosser Affiliations Northwestern University, Chicago, Illinois , MD, PhD c , x Ali Alikhan Affiliations University of Cincinnati, Cincinnati, Ohio , MD d , x Hilary E. Baldwin Affiliations SUNY Down State Medical Center–Brooklyn, New York, New York , MD e , x Diane S. Berson Affiliations Weill Cornell Medical College, New York, New York New York Presbyterian Hospital, New York, New York , MD f , g , x Whitney P. Bowe

2016 American Academy of Dermatology

157. Laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease

(GORD) is a common problem. It is caused by conditions that disturb the sphincter function at the lower end of the oesophagus, such as a hiatus hernia. Symptoms of GORD can be broadly grouped into those directly related to reflux episodes, such as heartburn, regurgitation, chest pain and nausea, and those caused by complications of the disease, including dysphagia and respiratory difficulties. Repeated episodes of GORD can damage the lining of the oesophagus and lead to oesophageal ulceration (...) , oesophageal stricture and Barrett's oesophagus. Laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease (IPG585) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 82.2 A NICE clinical guideline describes recommendations for the investigation and management of GORD and dyspepsia in adults. The standard treatments for symptomatic GORD are lifestyle modification and drug therapy. Patients

2017 National Institute for Health and Clinical Excellence - Interventional Procedures

158. Diverticular disease

removed. September 2017 — minor update. SPC update on quinolones to align all CKS topics prescribing advice. Prostatitis – chronic, Gonorrhoea, Pyelonephritis, Diarrhoea – prevention and advice for travellers, Dyspepsia – unidentified cause, Dyspepsia – proven functional, Dyspepsia – proven peptic ulcer, Diverticular disease, Gastroenteritis and Scrotal pain and swellings. July 2017 — reviewed. A literature search was conducted in June 2017 to identify evidence-based guidelines, UK policy, systematic (...) is a condition where diverticula are present without symptoms. It may present with a large, painless rectal bleed, or be found incidentally during investigation for other symptoms. Diverticular disease is a condition where diverticula cause symptoms, such as intermittent lower abdominal pain, without inflammation and infection. Diverticulitis is a condition where diverticula become inflamed and infected, typically causing severe lower abdominal pain, fever, general malaise, change in bowel habit

2019 NICE Clinical Knowledge Summaries

159. Gonorrhoea

, Diarrhoea – prevention and advice for travellers, Dyspepsia – unidentified cause, Dyspepsia – proven functional, Dyspepsia – proven peptic ulcer, Diverticular disease, Gastroenteritis and Scrotal pain and swellings. May to June 2017 — reviewed. A literature search was conducted in May 2017 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. Previous changes Previous changes December 2016 — minor update (...) guideline with the Royal College of General Practitioners Sexually transmitted infections in primary care [ ], the World Health Organization (WHO) Treatment of Neisseria gonorrhoea e [ ], and the British Medical Journal (BMJ) best practice guide Gonorrhoea infection [ ]. Signs and symptoms in a man What are the signs and symptoms of gonorrhoea in a man? Genital gonorrhoea infection is usually symptomatic in men. Uretheral infection causes mucopurulent or purulent urethral discharge in more than 80

2019 NICE Clinical Knowledge Summaries

160. Chronic kidney disease

[ ], and expert opinion in review articles on CKD [ ; ; ; ; ]. Assessment of symptoms The recommendations on history-taking are based on expert opinion in review articles [ ; ]. Over-the-counter medication such as nonsteroidal anti-inflammatory drugs (NSAIDs) and herbal medicines may be potentially nephrotoxic, and may interact with other prescribed medications to cause reduced renal function or progression of CKD. The cause of renal itch is not fully understood, but it may be secondary to deregulation (...) , abnormalities detected by histology, structural abnormalities detected by imaging, and a history of kidney transplantation, and/or A persistent reduction in renal function shown by a serum estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m 2 . CKD is classified based on the underlying cause, GFR, and proteinuria category. There are multiple possible causes and risk factors for CKD and its progression, including hypertension, diabetes mellitus, cardiovascular disease (CVD), acute

2019 NICE Clinical Knowledge Summaries

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>